Marshall Wace North America’s BioTelemetry, Inc. BEAT Stock Holding History

Marshall Wace North America’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,140	Closed	-$247K	–	1684
2019 Q2	$247K	Buy	+5,140	New	+$270K	﹤0.01%	1005
2019 Q1	–	Sell	-2,978	Closed	-$178K	–	2106
2018 Q4	$178K	Buy	+2,978	New	+$179K	﹤0.01%	977
2018 Q2	–	Sell	-22,762	Closed	-$707K	–	1931
2018 Q1	$707K	Buy	+22,762	New	+$749K	﹤0.01%	1083
2017 Q3	–	Sell	-127,129	Closed	-$4.2M	–	1710
2017 Q2	$4.2M	Buy	+127,129	New	+$3.79M	0.03%	552
2013 Q4	$158K	Buy	+19,920	New	+$186K	﹤0.01%	655
2013 Q3	–	Sell	-149,242	Closed	-$881K	–	793
2013 Q2	$881K	Buy	+149,242	New	+$502K	0.07%	240

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Marshall Wace North America's BEAT Position: Q3 2019 in Review

Marshall Wace North America sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 5,140 shares — an estimated $247K sold.

Marshall Wace North America first reported a position in BEAT in Q2 2013 and held it in 6 quarters. The position peaked at $4.2M in Q2 2017. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

Marshall Wace North America reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
Marshall Wace North America sold 5,140 BioTelemetry, Inc. shares in Q3 2019, an estimated $247K.
Marshall Wace North America first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 6 quarters.
Marshall Wace North America's BioTelemetry, Inc. position peaked at $4.2M in Q2 2017.
219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.